NCT00219622
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Riverside, California, United States
- Pfizer Investigational Site Clearwater, Florida, United States
- Pfizer Investigational Site Clearwater, Florida, United States